Veristat LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Veristat LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10633
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Veristat LLC (Veristat), a subsidiary of Veristat Holding Inc is a clinical research organization that conducts clinical trials. The organization offers services such as clinical project management, data management, clinical monitoring, biostatistics, medical writing, project management, regulatory submissions-FDA representation, CDISC implementation, and statistical and strategic consulting services. It also helps its clients to analyze, design, execute, standardize, and report clinical studies, among others. Veristat supports study phases in all therapeutic areas for medical products. The company serves organizations that develop biological products, vaccines, medical devices, diagnostics agents, immune therapies and gene therapies, among others. Veristat is headquartered in Southborough, Massachusetts, the US.

Veristat LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Veristat LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Veristat LLC, Medical Devices Deals, 2012 to YTD 2018 9
Veristat LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Veristat LLC, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Variance Development Partners Invests In Veristat, Clinical Research Organization 11
Partnerships 12
Hemostemix Enters into Agreement with Topstone Research 12
Veristat Enters into Partnership with Cidara Therapeutics 13
Veristat Extends Partnership with EndoCeutics 14
Molecular Templates Enters into Agreement with Veristat 15
Veristat Enters into Agreement with Karyopharm Therapeutics 16
Veristat Partners with Multi-Regional Clinical Trials Center 17
Certara Partners with Veristat 18
Acquisition 19
Veristat Acquires Topstone Research 19
Veristat Acquires Spero Oncology 20
Veristat LLC – Key Competitors 21
Veristat LLC – Key Employees 22
Veristat LLC – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Veristat LLC, Pharmaceuticals & Healthcare, Key Facts 2
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Veristat LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Veristat LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Veristat LLC, Medical Devices Deals, 2012 to YTD 2018 9
Veristat LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Variance Development Partners Invests In Veristat, Clinical Research Organization 11
Hemostemix Enters into Agreement with Topstone Research 12
Veristat Enters into Partnership with Cidara Therapeutics 13
Veristat Extends Partnership with EndoCeutics 14
Molecular Templates Enters into Agreement with Veristat 15
Veristat Enters into Agreement with Karyopharm Therapeutics 16
Veristat Partners with Multi-Regional Clinical Trials Center 17
Certara Partners with Veristat 18
Veristat Acquires Topstone Research 19
Veristat Acquires Spero Oncology 20
Veristat LLC, Key Competitors 21
Veristat LLC, Key Employees 22
Veristat LLC, Other Locations 23
Veristat LLC, Subsidiaries 23

List of Figures
Veristat LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Veristat LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Veristat LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Veristat LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Veristat LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dicerna Pharmaceuticals Inc (DRNA):企業の財務・戦略的SWOT分析
    Summary Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that offers therapies. The company discovers and develops treatments for rare inherited diseases including liver and for cancers that are genetically defined. It offers RNAi technology platform GalXCTM, which is a advances …
  • Shri Lakshmi Defence Solutions Ltd.:企業の戦略・SWOT・財務情報
    Shri Lakshmi Defence Solutions Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shri Lakshmi Defence Solutions Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Banque Internationale à Luxembourg SA:企業の戦略・SWOT・財務情報
    Banque Internationale à Luxembourg SA - Strategy, SWOT and Corporate Finance Report Summary Banque Internationale à Luxembourg SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • OBB-Infrastruktur AG:企業の戦略的SWOT分析
    OBB-Infrastruktur AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Screen Holdings Co Ltd (7735):企業の財務・戦略的SWOT分析
    Screen Holdings Co Ltd (7735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Taiwan Liposome Co Ltd (4152):企業の財務・戦略的SWOT分析
    Summary Taiwan Liposome Co Ltd (TLC) is a clinical-stage pharmaceutical company, which develops and commercializes novel nanomedicines based on drug delivery technology platform. The company’s pipeline products include TLC599, TLC590, TLC399 and TLC178. Its TLC 178 is used for the treatment of adult …
  • Standard Bank Group Ltd (SBK):企業の財務・戦略的SWOT分析
    Standard Bank Group Ltd (SBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Transgene Biotek Ltd (526139):製薬・医療:M&Aディール及び事業提携情報
    Summary Transgene Biotek Ltd (Transgene) is a biotechnology company that develops and commercializes biogeneric drugs, vaccines and biotech products. The company develops products in the areas of oncology, auto-immunity, drug delivery and bio generics. Its products include TBL-0404, TBL-0905, TBL -0 …
  • Circle Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Circle Pharma Inc (Circle Pharma) is a developer of cell permeable macrocyclic peptide therapies by combining structure-based computational design and synthetic chemistry. The company’s automated chemistry synthesis enable to assess, in parallel, multiple design hypotheses for given target, …
  • The Bangchak Petroleum PCL (BCP):石油・ガス:M&Aディール及び事業提携情報
    Summary The Bangchak Petroleum PCL (Bangchak) is an oil and gas company. It carries out import of crude oil from both indigenous and overseas sources, and refines it into finished petroleum products. Its refinery produces gasoline, gasohol and diesel products. The company markets its petroleum produ …
  • United States Cellular Corp (USM):企業の財務・戦略的SWOT分析
    United States Cellular Corp (USM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Goldman Sachs Group Inc:戦略・SWOT・企業財務分析
    Goldman Sachs Group Inc - Strategy, SWOT and Corporate Finance Report Summary Goldman Sachs Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • CSS Industries, Inc. (CSS):企業の財務・戦略的SWOT分析
    CSS Industries, Inc. (CSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Venator Materials PLC (VNTR):企業の財務・戦略的SWOT分析
    Venator Materials PLC (VNTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Trillion Energy International Inc (PKPL):企業の財務・戦略的SWOT分析
    Summary Trillion Energy International Inc (Trillion Energy) formerly Park Place Energy Inc, is an oil and gas company that offers exploration and development of oil and natural gas. The company offers various oil and gas services such as drilling, exploration, development, production, distribution a …
  • Auswide Bank Ltd (ABA):企業の財務・戦略的SWOT分析
    Auswide Bank Ltd (ABA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Aecon Group Inc (ARE):企業の財務・戦略的SWOT分析
    Aecon Group Inc (ARE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • American Financial Group, Inc.:企業の戦略・SWOT・財務情報
    American Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Vulcan Materials Company
    Vulcan Materials Company - Strategy, SWOT and Corporate Finance Report Summary Vulcan Materials Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ContraVir Pharmaceuticals Inc (CTRV):製薬・医療:M&Aディール及び事業提携情報
    Summary ContraVir Pharmaceuticals Inc (ContraVir) is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆